Risk of chronic kidney disease in type 2 diabetes determined by polymorphisms in NOS3, APOB, KCNJ11, TCF7L2 genes as compound effect of risk genotypes combination
Genetic susceptibility plays an important role in the risk of developing chronic complications in patients with type 2 diabetes mellitus (T2DM). Aims. In this study, we evaluated the possible association of the polymorphic variants that encode key renal damage mediators (endothelial dysfunction, li...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN RU |
| Publicado: |
Endocrinology Research Centre
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/237d2a0144b948ea8e9f69bc14592804 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:237d2a0144b948ea8e9f69bc14592804 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:237d2a0144b948ea8e9f69bc145928042021-11-14T09:00:19ZRisk of chronic kidney disease in type 2 diabetes determined by polymorphisms in NOS3, APOB, KCNJ11, TCF7L2 genes as compound effect of risk genotypes combination2072-03512072-037810.14341/DM2014323-30https://doaj.org/article/237d2a0144b948ea8e9f69bc145928042014-10-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/6693https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Genetic susceptibility plays an important role in the risk of developing chronic complications in patients with type 2 diabetes mellitus (T2DM). Aims. In this study, we evaluated the possible association of the polymorphic variants that encode key renal damage mediators (endothelial dysfunction, lipid metabolism and insulin secretion/sensitivity) with the risk of chronic kidney disease (CKD) in patients with T2DM. Materials and Methods. We enrolled 435 patients with T2DM using case-control study design. In 253 patients, we used non-overlapping criteria to form groups with/without CKD (defined as GFR=10 years) (n=75 and 178, respectively) and analysed the following 4 polymorphic markers: I/D in ACE, ecNOS4a/4b in NOS3, I/D in APOB and e2/e3/e4 in APOE genes. We then divided 182 patients in groups with/without CKD (n=38 and 144, respectively) regardless of the duration of diabetes and studied pro12ala in PPARG2, rs5219 in KCNJ11, rs12255372 in TCF7L2 and rs13266634 in SLC30A8 genes. 2 test, and data were expressed as odds ratios (ORs) with 95% confidence intervals (CIs). Values of pAnna Viktorovna ZheleznyakovaNadezhda Olegovna LebedevaOlga Konstantinovna VikulovaValery Vyacheslavovich NosikovMinara Shamkhalovna ShamkhalovaMarina Vladimirovna ShestakovaEndocrinology Research Centrearticlediabetes mellitusgenesckdnos3apobtcf7l2kcnj11Nutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 17, Iss 3, Pp 23-30 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN RU |
| topic |
diabetes mellitus genes ckd nos3 apob tcf7l2 kcnj11 Nutritional diseases. Deficiency diseases RC620-627 |
| spellingShingle |
diabetes mellitus genes ckd nos3 apob tcf7l2 kcnj11 Nutritional diseases. Deficiency diseases RC620-627 Anna Viktorovna Zheleznyakova Nadezhda Olegovna Lebedeva Olga Konstantinovna Vikulova Valery Vyacheslavovich Nosikov Minara Shamkhalovna Shamkhalova Marina Vladimirovna Shestakova Risk of chronic kidney disease in type 2 diabetes determined by polymorphisms in NOS3, APOB, KCNJ11, TCF7L2 genes as compound effect of risk genotypes combination |
| description |
Genetic susceptibility plays an important role in the risk of developing chronic complications in patients with type 2 diabetes mellitus (T2DM). Aims. In this study, we evaluated the possible association of the polymorphic variants that encode key renal damage mediators (endothelial dysfunction, lipid metabolism and insulin secretion/sensitivity) with the risk of chronic kidney disease (CKD) in patients with T2DM. Materials and Methods. We enrolled 435 patients with T2DM using case-control study design. In 253 patients, we used non-overlapping criteria to form groups with/without CKD (defined as GFR=10 years) (n=75 and 178, respectively) and analysed the following 4 polymorphic markers: I/D in ACE, ecNOS4a/4b in NOS3, I/D in APOB and e2/e3/e4 in APOE genes. We then divided 182 patients in groups with/without CKD (n=38 and 144, respectively) regardless of the duration of diabetes and studied pro12ala in PPARG2, rs5219 in KCNJ11, rs12255372 in TCF7L2 and rs13266634 in SLC30A8 genes. 2 test, and data were expressed as odds ratios (ORs) with 95% confidence intervals (CIs). Values of p |
| format |
article |
| author |
Anna Viktorovna Zheleznyakova Nadezhda Olegovna Lebedeva Olga Konstantinovna Vikulova Valery Vyacheslavovich Nosikov Minara Shamkhalovna Shamkhalova Marina Vladimirovna Shestakova |
| author_facet |
Anna Viktorovna Zheleznyakova Nadezhda Olegovna Lebedeva Olga Konstantinovna Vikulova Valery Vyacheslavovich Nosikov Minara Shamkhalovna Shamkhalova Marina Vladimirovna Shestakova |
| author_sort |
Anna Viktorovna Zheleznyakova |
| title |
Risk of chronic kidney disease in type 2 diabetes determined by polymorphisms in NOS3, APOB, KCNJ11, TCF7L2 genes as compound effect of risk genotypes combination |
| title_short |
Risk of chronic kidney disease in type 2 diabetes determined by polymorphisms in NOS3, APOB, KCNJ11, TCF7L2 genes as compound effect of risk genotypes combination |
| title_full |
Risk of chronic kidney disease in type 2 diabetes determined by polymorphisms in NOS3, APOB, KCNJ11, TCF7L2 genes as compound effect of risk genotypes combination |
| title_fullStr |
Risk of chronic kidney disease in type 2 diabetes determined by polymorphisms in NOS3, APOB, KCNJ11, TCF7L2 genes as compound effect of risk genotypes combination |
| title_full_unstemmed |
Risk of chronic kidney disease in type 2 diabetes determined by polymorphisms in NOS3, APOB, KCNJ11, TCF7L2 genes as compound effect of risk genotypes combination |
| title_sort |
risk of chronic kidney disease in type 2 diabetes determined by polymorphisms in nos3, apob, kcnj11, tcf7l2 genes as compound effect of risk genotypes combination |
| publisher |
Endocrinology Research Centre |
| publishDate |
2014 |
| url |
https://doaj.org/article/237d2a0144b948ea8e9f69bc14592804 |
| work_keys_str_mv |
AT annaviktorovnazheleznyakova riskofchronickidneydiseaseintype2diabetesdeterminedbypolymorphismsinnos3apobkcnj11tcf7l2genesascompoundeffectofriskgenotypescombination AT nadezhdaolegovnalebedeva riskofchronickidneydiseaseintype2diabetesdeterminedbypolymorphismsinnos3apobkcnj11tcf7l2genesascompoundeffectofriskgenotypescombination AT olgakonstantinovnavikulova riskofchronickidneydiseaseintype2diabetesdeterminedbypolymorphismsinnos3apobkcnj11tcf7l2genesascompoundeffectofriskgenotypescombination AT valeryvyacheslavovichnosikov riskofchronickidneydiseaseintype2diabetesdeterminedbypolymorphismsinnos3apobkcnj11tcf7l2genesascompoundeffectofriskgenotypescombination AT minarashamkhalovnashamkhalova riskofchronickidneydiseaseintype2diabetesdeterminedbypolymorphismsinnos3apobkcnj11tcf7l2genesascompoundeffectofriskgenotypescombination AT marinavladimirovnashestakova riskofchronickidneydiseaseintype2diabetesdeterminedbypolymorphismsinnos3apobkcnj11tcf7l2genesascompoundeffectofriskgenotypescombination |
| _version_ |
1718429512400633856 |